Bastiaan Evers

4.5k citations

39 papers · 2.4k indexed · h-index 21

Impact in

Aging top 5%
Oncology top 2%
- PARP inhibition in cancer therapy
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways

Papers in ⓘ

Molecular Biology 25
- CRISPR and Genetic Engineering 8
- DNA Repair Mechanisms 8
- Genomics and Chromatin Dynamics 3
Oncology 9
- PARP inhibition in cancer therapy 5
- Cancer Cells and Metastasis 3

Co-authors: Jos Jonkers (10 shared papers)René Bernards (8 shared papers)Roderick L. Beijersbergen (8 shared papers)Katarzyna Jastrzebski (2 shared papers)Patrick W.B. Derksen (4 shared papers)Xiaoling Liu (2 shared papers)Wipawadee Grernrum (1 shared paper)John Zevenhoven (2 shared papers)
Journals: Surgery (4 papers)Annals of Surgery (4 papers)Cell Reports (3 papers)Cancer Research (3 papers)Clinical Cancer Research (2 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Bastiaan Evers

38 papers receiving 2.4k citations

Peers

Countries citing papers authored by Bastiaan Evers

Since Specialization

Citations

This map shows the geographic impact of Bastiaan Evers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bastiaan Evers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bastiaan Evers more than expected).

Fields of papers citing papers by Bastiaan Evers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bastiaan Evers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bastiaan Evers. The network helps show where Bastiaan Evers may publish in the future.

Co-authors

The 25 scholars most cited alongside Bastiaan Evers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bastiaan Evers Line = papers co-authored together Bastiaan Evers links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis Cancer Cell ·Patrick W.B. Derksen, Xiaoling Liu, Francis N. Saridin, Hanneke van der Gulden, John Zevenhoven, Bastiaan Evers, Judy R. van Beijnum, Arjan W. Griffioen, Jacqueline Vink, Paul Krimpenfort, Johannes L. Peterse, Robert D. Cardiff, Anton Berns, Jos Jonkers	2006	452
2	CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes Nature Biotechnology ·Bastiaan Evers, Katarzyna Jastrzebski, Jeroen P M Heijmans, Wipawadee Grernrum, Roderick L. Beijersbergen, René Bernards	2016	293
3	Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and Cisplatin Clinical Cancer Research ·Bastiaan Evers, Rinske Drost, Eva Schut, Michiel de Bruin, Eline van der Burg, Patrick W.B. Derksen, Henne Holstege, Xiaoling Liu, Ellen van Drunen, H. Berna Beverloo, Graeme C.M. Smith, Niall M.B. Martin, Alan Lau, Mark J. O’Connor, Jos Jonkers	2008	259
4	High-Throughput Functional Genetic and Compound Screens Identify Targets for Senescence Induction in Cancer Cell Reports ·Liqin Wang, Rodrigo Leite de Oliveira, Cun Wang, João M. Fernandes Neto, Sara Mainardi, Bastiaan Evers, Cor Lieftink, Ben Morris, Fleur Jochems, Lisa Willemsen, Roderick L. Beijersbergen, René Bernards	2017	163
5	Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis Proceedings of the National Academy of Sciences ·Christophe Desmet, Tristan Gallenne, Alexandre Prieur, Fabien Reyal, Nils L. Visser, Ben S. Wittner, Marjon A. Smit, Thomas R. Geiger, Jamila Laoukili, Sedef Iskit, Boris Rodenko, Wilbert Zwart, Bastiaan Evers, Hugo M. Horlings, Abderrahrim Ajouaou, John Zevenhoven, M. van Vliet, Sridhar Ramaswamy, Lodewyk F.A. Wessels, Daniel S. Peeper	2013	136
6	PTPN11 Is a Central Node in Intrinsic and Acquired Resistance to Targeted Cancer Drugs Cell Reports ·Anirudh Prahallad, Guus J.J.E. Heynen, Giovanni Germano, Stefan M. Willems, Bastiaan Evers, Loredana Vecchione, Valentina Gambino, Cor Lieftink, Roderick L. Beijersbergen, Federica Di Nicolantonio, Alberto Bardelli, René Bernards	2015	114
7	The CST Complex Mediates End Protection at Double-Strand Breaks and Promotes PARP Inhibitor Sensitivity in BRCA1-Deficient Cells Cell Reports ·Marco Barazas, Stefano Annunziato, Stephen J. Pettitt, Inge de Krijger, Hind Ghezraoui, Stefan J. Roobol, Catrin Lutz, Jessica Frankum, Fei Song, Rachel Brough, Bastiaan Evers, Ewa Gogola, Jinhyuk Bhin, Marieke van de Ven, Dik C. van Gent, Jacqueline J.L. Jacobs, J. Ross Chapman, Christopher J. Lord, Jos Jonkers, Sven Rottenberg	2018	102
8	Bmi1 Regulates Stem Cells and Proliferation and Differentiation of Committed Cells in Mammary Epithelium Current Biology ·Alexandra M Pietersen, Bastiaan Evers, Asheeta A. Prasad, Ellen Tanger, Paulien Cornelissen‐Steijger, Jos Jonkers, Maarten van Lohuizen	2008	96
9	BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A Breast Cancer Research ·Julian Puppe, Rinske Drost, Xiaoling Liu, Simon A. Joosse, Bastiaan Evers, Paulien Cornelissen‐Steijger, Petra M. Nederlof, Qiang Yu, Jos Jonkers, Maarten van Lohuizen, Alexandra M Pietersen	2009	95
10	Targeting homologous recombination repair defects in cancer Trends in Pharmacological Sciences ·Bastiaan Evers, Thomas Helleday, Jos Jonkers	2010	82
11	ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors Oncogene ·Katrien Berns, Joseph J. Caumanns, E. Marielle Hijmans, Annemiek M.C. Gennissen, Tesa Severson, Bastiaan Evers, G. Bea A. Wisman, Gert Jan Meersma, Cor Lieftink, Roderick L. Beijersbergen, Hiroaki Itamochi, Ate G.J. van der Zee, Steven de Jong, René Bernards	2018	77
12	Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer Journal of Hepatology ·Cun Wang, Haojie Jin, Dongmei Gao, Cor Lieftink, Bastiaan Evers, Guang‐Zhi Jin, Xue Zheng, Liqin Wang, Roderick L. Beijersbergen, Wenxin Qin, René Bernards	2018	73
13	A High-Throughput Pharmaceutical Screen Identifies Compounds with Specific Toxicity against BRCA2-Deficient Tumors Clinical Cancer Research ·Bastiaan Evers, Eva Schut, Eline van der Burg, Tanya M. Braumuller, David A. Egan, Henne Holstege, Pauline Edser, David J. Adams, Richard Wade‐Martins, Peter Bouwman, Jos Jonkers	2009	66
14	The PARP Inhibitor AZD2461 Provides Insights into the Role of PARP3 Inhibition for Both Synthetic Lethality and Tolerability with Chemotherapy in Preclinical Models Cancer Research ·Lenka Oplustil O’Connor, Stuart L. Rulten, Aaron Cranston, Rajesh Odedra, H. Shelton Brown, Janneke E. Jaspers, Louise Jones, Charlotte Knights, Bastiaan Evers, Attilla Ting, Robert H. Bradbury, Marina Pajic, Sven Rottenberg, Jos Jonkers, David A. Rudge, Niall M.B. Martin, Keith W. Caldecott, Alan Lau, Mark J. O’Connor	2016	60
15	Caloric Restriction Increases the Expression of Heat Shock Protein in the Gut Annals of Surgery ·John A. Ehrenfried, Bastiaan Evers, Kyo U. Chu, Courtney M. Townsend, James C. Thompson	1996	51
16	Role of Bombesin on Gut Mucosal Growth Annals of Surgery ·Kyo U. Chu, Bastiaan Evers, Jin Ishizuka, Courtney M. Townsend, James C. Thompson	1995	41
17	DNA damage-induced transcription stress triggers the genome-wide degradation of promoter-bound Pol II Nature Communications ·Barbara Steurer, Roel C. Janssens, Marit E. Geijer, Fernando Aprile-Garcia, Bart Geverts, Arjan F. Theil, Barbara Hummel, Martin E. van Royen, Bastiaan Evers, René Bernards, Adriaan B. Houtsmuller, Ritwick Sawarkar, Jurgen A. Marteijn	2022	35
18	Bombesin Improves Survival from Methotrexate-Induced Enterocolitis Annals of Surgery ·Kyo U. Chu, Shunichi Higashide, Bastiaan Evers, Srinivasan Rajaraman, Jin Ishizuka, C. M. Townsend, James C. Thompson	1994	30
19	Macrophage p53 controls macrophage death in atherosclerotic lesions of apolipoprotein E deficient mice Atherosclerosis ·Lianne S.M. Boesten, A. Susanne M. Zadelaar, Anita van Nieuwkoop, Lihui Hu, Amina F.A.S. Teunisse, Aart G. Jochemsen, Bastiaan Evers, Bob van de Water, Marion J. Gijbels, Bart J.M. van Vlijmen, Louis M. Havekes, Menno P.J. de Winther	2009	27
20	A genome-wide IR-induced RAD51 foci RNAi screen identifies CDC73 involved in chromatin remodeling for DNA repair Cell Discovery ·Patrick Herr, Cecilia Lundin, Bastiaan Evers, Daniel Ebner, Christina Bauerschmidt, Guy L. Kingham, Timea Palmai‐Pallag, Oliver Mortusewicz, Oliver Frings, Erik L. L. Sonnhammer, Thomas Helleday	2015	26

About Bastiaan Evers

Bastiaan Evers is a scholar working on Molecular Biology, Oncology, Genetics, Pathology and Forensic Medicine and Surgery, having authored 39 papers that have together received 2.4k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (8 papers), DNA Repair Mechanisms (8 papers), PARP inhibition in cancer therapy (5 papers), Cancer Cells and Metastasis (3 papers), BRCA gene mutations in cancer (3 papers), Cancer Mechanisms and Therapy (3 papers), Genomics and Chromatin Dynamics (3 papers) and Digestive system and related health (3 papers). The work is most often cited by research in Aging (65 citations), Oncology (995 citations), Molecular Biology (1.8k citations), Cancer Research (369 citations) and Physiology (73 citations). Bastiaan Evers has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Jos Jonkers, René Bernards, Roderick L. Beijersbergen, Katarzyna Jastrzebski, Patrick W.B. Derksen, Xiaoling Liu, Wipawadee Grernrum, John Zevenhoven, Cor Lieftink and Thomas Helleday. Their work appears in journals such as Surgery, Annals of Surgery, Cell Reports, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact